This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Feb 20;28(6):e107-9.

doi: 10.1200/JCO.2009.25.5950. Epub 2009 Dec 21.

Successful treatment with meloxicam, a cyclooxygenase-2 inhibitor, of patients with extra-abdominal desmoid tumors: a pilot study

Yoshihiro Nishida, Satoshi Tsukushi, Yoji Shido, Junji Wasa, Naoki Ishiguro, Yoshihisa Yamada

PMID: 20026797
DOI: 10.1200/JCO.2009.25.5950

Successful treatment with meloxicam, a cyclooxygenase-2 inhibitor, of patients with extra-abdominal desmoid tumors: a pilot study

Yoshihiro Nishida et al. J Clin Oncol. 2010.

. 2010 Feb 20;28(6):e107-9.

doi: 10.1200/JCO.2009.25.5950. Epub 2009 Dec 21.

Authors

Yoshihiro Nishida, Satoshi Tsukushi, Yoji Shido, Junji Wasa, Naoki Ishiguro, Yoshihisa Yamada

PMID: 20026797
DOI: 10.1200/JCO.2009.25.5950

No abstract available

PubMed Disclaimer

Similar articles

CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.
Hamada S, Futamura N, Ikuta K, Urakawa H, Kozawa E, Ishiguro N, Nishida Y. Hamada S, et al. PLoS One. 2014 May 1;9(5):e96391. doi: 10.1371/journal.pone.0096391. eCollection 2014. PLoS One. 2014. PMID: 24788118 Free PMC article.
Nuclear expression of β-catenin predicts the efficacy of meloxicam treatment for patients with sporadic desmoid tumors.
Hamada S, Urakawa H, Kozawa E, Futamura N, Ikuta K, Shimoyama Y, Nakamura S, Ishiguro N, Nishida Y. Hamada S, et al. Tumour Biol. 2014 May;35(5):4561-6. doi: 10.1007/s13277-013-1600-7. Epub 2014 Jan 5. Tumour Biol. 2014. PMID: 24390670
Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis.
Sakai T, Nishida Y, Hamada S, Koike H, Ikuta K, Ota T, Ishiguro N. Sakai T, et al. Diagn Pathol. 2017 Aug 29;12(1):66. doi: 10.1186/s13000-017-0654-z. Diagn Pathol. 2017. PMID: 28851389 Free PMC article.
[Meloxicam (Movalis)].
Kaliterna DM. Kaliterna DM. Reumatizam. 2007;54(2):81-2. Reumatizam. 2007. PMID: 18351150 Review. Croatian. No abstract available.
[Pharma-Clinics. The drug of the month. Meloxicam (Mobic)].
Scheen AJ. Scheen AJ. Rev Med Liege. 1997 Apr;52(4):309-11. Rev Med Liege. 1997. PMID: 9273628 Review. French. No abstract available.

See all similar articles

Cited by

Extra-abdominal desmoid tumours: a review of the literature.
Molloy AP, Hutchinson B, O'Toole GC. Molloy AP, et al. Sarcoma. 2012;2012:578052. doi: 10.1155/2012/578052. Epub 2012 Aug 16. Sarcoma. 2012. PMID: 22966217 Free PMC article.
Desmoid tumor-associated pain is dependent on mast cell expression of cyclooxygenase-2.
Emori M, Kaya M, Mitsuhashi T, Asanuma H, Yamashita T. Emori M, et al. Diagn Pathol. 2014 Jan 20;9:14. doi: 10.1186/1746-1596-9-14. Diagn Pathol. 2014. PMID: 24443892 Free PMC article.
Molecular pathogenesis of desmoid tumor and the role of γ-secretase inhibition.
Federman N. Federman N. NPJ Precis Oncol. 2022 Sep 6;6(1):62. doi: 10.1038/s41698-022-00308-1. NPJ Precis Oncol. 2022. PMID: 36068332 Free PMC article. Review.
Recent Advances in Desmoid Tumor Therapy.
Napolitano A, Mazzocca A, Spalato Ceruso M, Minelli A, Baldo F, Badalamenti G, Silletta M, Santini D, Tonini G, Incorvaia L, Vincenzi B. Napolitano A, et al. Cancers (Basel). 2020 Aug 1;12(8):2135. doi: 10.3390/cancers12082135. Cancers (Basel). 2020. PMID: 32752153 Free PMC article. Review.
Autophagy inhibition overcomes sorafenib resistance in S45F-mutated desmoid tumors.
Braggio D, Koller D, Jin F, Siva N, Zewdu A, Lopez G, Batte K, Casadei L, Welliver M, Strohecker AM, Lev D, Pollock RE. Braggio D, et al. Cancer. 2019 Aug 1;125(15):2693-2703. doi: 10.1002/cncr.32120. Epub 2019 Apr 12. Cancer. 2019. PMID: 30980399 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program